Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Share-based Compensation (2021 - 2026)

HeartSciences (HSCS) has disclosed Share-based Compensation for 5 consecutive years, with $436884.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Share-based Compensation rose 1081.59% year-over-year to $436884.0, compared with a TTM value of $851280.0 through Oct 2025, up 361.19%, and an annual FY2025 reading of $249884.0, down 38.3% over the prior year.
  • Share-based Compensation was $436884.0 for Q4 2025 at HeartSciences, up from $174558.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $436884.0 in Q4 2025 and bottomed at -$49853.0 in Q2 2022.
  • Average Share-based Compensation over 5 years is $83670.7, with a median of $87196.0 recorded in 2024.
  • The sharpest move saw Share-based Compensation surged 9105.43% in 2022, then tumbled 142.05% in 2024.
  • Year by year, Share-based Compensation stood at $26.0 in 2021, then surged by 7276.92% to $1918.0 in 2022, then surged by 5418.25% to $105840.0 in 2023, then crashed by 142.05% to -$44508.0 in 2024, then skyrocketed by 1081.59% to $436884.0 in 2025.
  • Business Quant data shows Share-based Compensation for HSCS at $436884.0 in Q4 2025, $174558.0 in Q3 2025, and $95945.0 in Q2 2025.